Pharmacy news, jobs, continuing education, community and more.
SAN DIEGO, INDIANAPOLIS, and WALTHAM, Mass., – Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced that the companies have submitted their reply to a complete response letter issued in October 2010 by the U.S. Food and Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable [...]
INDIANAPOLIS – For the first time, Eli Lilly and Company (NYSE: LLY) employees worldwide can donate to more than 800 grassroots projects across the globe and have their donations matched by the Eli Lilly and Company Foundation—doubling the value and impact of each employee’s charitable contribution. Lilly is partnering with the GlobalGiving Foundation to offer [...]
INDIANAPOLIS, – Eli Lilly and Company (NYSE: LLY) and the U.S. Department of Energy’s Argonne National Laboratory announced today the completion of Lilly’s $2 million upgrade to the company’s research-guided beamline, located at the Advanced Photon Source (APS) at Argonne’s campus outside of Chicago. The APS is a U.S. Department of Energy Office of Science [...]
INDIANAPOLIS, – Eli Lilly and Company (NYSE: LLY) announced that it has made a charitable contribution to the Patient Advocate Foundation (PAF). The donation will enable expansion of the foundation’s patient services programs, including Case Management and Co-Pay Relief (CPR) Programs in support of a new fund for patients with nonsquamous non-small cell lung cancer [...]
INDIANAPOLIS, – Fionnuala Walsh, Ph.D., will join the executive committee of Eli Lilly and Company (NYSE: LLY) on July 1. Walsh will continue in her current role as Lilly’s senior vice president of global quality, reporting to John Lechleiter, Ph.D., chairman, president, and CEO, and working to ensure Lilly continues to maintain high quality standards [...]
INDIANAPOLIS – Eli Lilly and Company (NYSE: LLY) announced Phase I data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma. Results from the Phase I study will be presented on Sunday, June 5 at 11:30 a.m. CDT during the [...]
INDIANAPOLIS and PHILADELPHIA, March 18, 2011 – Eli Lilly and Company (NYSE: LLY) and its wholly owned subsidiary, Avid Radiopharmaceuticals, Inc., have received a complete response letter from the U.S. Food and Drug Administration (FDA) for their New Drug Application (NDA) for Amyvid™ (florbetapir F 18 injection), a Positron Emission Tomography (PET) imaging agent under [...]
INDIANAPOLIS, Feb. 11, 2011- Eli Lilly and Company (NYSE: LLY) today announced that Sue Mahony, currently senior vice president of human resources and diversity, has been named senior vice president and president of Lilly Oncology. In this new role she continues to report to John Lechleiter, Ph.D., Lilly chairman, president, and CEO, and she remains [...]
SAN DIEGO, INDIANAPOLIS, and WALTHAM, Mass., April 22, 2010 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced that the companies have submitted their reply to a complete response letter issued last month by the U.S. Food and Drug Administration (FDA) after review of the New [...]
INDIANAPOLIS, March 17, 2010 - Eli Lilly and Company (NYSE: LLY) today issued a statement and details regarding the stolen company products from its distribution operations in Enfield, Connecticut on Sunday, March 14. Lilly is working with the U.S. Food and Drug Administration’s Office of Criminal Investigations (FDA), and other law enforcement officials, to recover cases [...]
Featured Jobs
© Rx Times 2006 - 2012. All rights reserved. All products denoted with ™ and ® are trademarks or registered trademarks of Rx Times, LLC and/or its affiliates.